Suicidality in pediatric patients treated with antidepressant drugs.

By T. Hammad, T. Laughren, J. Racoosin. Archives of General Psychiatry, 2006

1,036 citations recorded by the source corpus.

Subfields: Clinical Psychology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/a28eefafd6cc4b81a79a3f62af7ccf8f96a894db

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. D. Brent
2. Madelyn S. Gould

In Psychiatry and Mental health

1. Madelyn S. Gould

Citations in the corpus

• Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. (2007, methodology): “, slow metabolizers or variations in genetic polymorphisms) are related to increased risk of suicidality (Apter et al., 2006; Brent, 2004; Bridge et al., 2007; Hammad et al., 2006; Safer and Zito, 2006).”
• Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. (2007, methodology): “(33) in the FDA’s safety analysis, for example—some discussion of the limitations of these subsequent analyses is warranted.”